Skip to main content
AGL logo

AGL · agilon health, inc.

Track AGL — free
$96.90 +8.00 (+9.00%) At close · Aug 14
Market Cap
$1.63B
Shares
16.79M

agilon health, inc. Earnings Call Transcripts

Every quarterly earnings call for agilon health, inc. (AGL) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-05
agilon health Sets Date to Report Second Quarter 2026 Financial Results
Positive tone Guidance raise and quarterly outperformance Burden of illness / quality program value Clinical programs (CHF, dementia, lung health)
Revenue
$1.49B
▲ 7.2% YoY
Diluted EPS
$1.04
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-23
Truist Securities Healthcare Disruptors & Digital Health Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
agilon health, inc. Q1 FY2026 Earnings Call
Confident tone Risk adjustment and regulatory environment (CMS/LEAD) Data pipeline and analytics 2026 guidance raise
Revenue
$1.42B
▼ 7.3% YoY
Diluted EPS
$2.94
▲ 302.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
agilon health, inc. Q4 FY2025 Earnings Call
Balanced tone Cost trend and utilization pressure Quality programs and Stars ratings 2026 financial guidance and outlook
Revenue
$1.57B*
▲ 3.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
agilon health, inc. Q3 FY2025 Earnings Call
Balanced tone Clinical Programs and Burden of Illness (BOI) Enhanced Data Pipeline and Analytics Stars Ratings and Quality Performance
Revenue
$1.44B
▼ 1.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2025-09-30
2025 Jefferies Healthcare Services Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-04
agilon health, inc. Q2 FY2025 Earnings Call
Cautious tone Execution and Accountability 2026 Outlook and Strategic Initiatives Risk Adjustment / 2024 Baseline
Revenue
$1.39B
▼ 5.9% YoY
Diluted EPS
$-6.31
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
agilon health, inc. Q1 FY2025 Earnings Call
Positive tone Part D and supplemental benefit exposure Q1 results and full-year guidance Medicare Advantage and CMS rate environment
Revenue
$1.53B
▼ 4.5% YoY
Diluted EPS
$0.73
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
agilon health, inc. Q4 FY2024 Earnings Call
Balanced tone Part D exposure reduction Medicare Advantage cost trend and utilization cycle Path to profitability and cash flow breakeven
Revenue
$1.52B*
▲ 44.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
agilon health, inc. Q3 FY2024 Earnings Call
Cautious tone Data lag, risk adjustment, and claims information challenges 2025 jumping-off point and business mix improvement Disappointing Q3 financial results and lowered guidance
Revenue
$1.45B
▲ 27.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
agilon health, inc. Q2 FY2024 Earnings Call
Cautious tone Medical cost trends and utilization Membership and revenue guidance PCP engagement and high-risk patient management
Revenue
$1.48B
▲ 38.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
agilon health, inc. Q1 FY2024 Earnings Call
Positive tone Guidance and quarterly performance Medicare Advantage funding environment Medical cost trend and utilization
Revenue
$1.60B
▲ 52.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
agilon health, inc. Q4 FY2023 Earnings Call
Cautious tone 2023 results miss and lowered 2024 guidance Balance sheet and liquidity Higher utilization and medical cost trend
Revenue
$1.06B*
▲ 185.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
agilon health, inc. Q3 FY2023 Earnings Call
Revenue
$1.14B
▲ 63.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
agilon health, inc. Q2 FY2023 Earnings Call
Revenue
$1.07B
▲ 59.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
agilon health, inc. Q1 FY2023 Earnings Call
Revenue
$1.05B
▲ 61.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-01
agilon health, inc. Q4 FY2022 Earnings Call
Revenue
$369.78M*
▲ 145.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
agilon health, inc. Q3 FY2022 Earnings Call
Revenue
$694.86M
▲ 51.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
agilon health, inc. Q2 FY2022 Earnings Call
Revenue
$670.13M
▲ 34.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
agilon health, inc. Q1 FY2022 Earnings Call
Revenue
$653.45M
▲ 58.2% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-04
agilon health, inc. Q4 FY2021 Earnings Call
Revenue
$150.82M*
▼ 53% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-29
agilon health, inc. Q3 FY2021 Earnings Call
Revenue
$458.61M
▲ 46.7% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
agilon health, inc. Q2 FY2021 Earnings Call
Revenue
$498.96M
▲ 69.9% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-27
agilon health, inc. Q1 FY2021 Earnings Call
Revenue
$413.10M
▲ 41.9% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 earnings calls
Key facts CIK 1831097 CUSIP 00857U206 13F (30d) 171 filings 168 filers Visit website Investor relations